U.S. market Open. Closes in 4 hours 28 minutes

BIAF | bioAffinity Technologies, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
Revenue2.53M4.80KN/AN/AN/A
Cost of Revenue1.99M467.004.82K22.24K40.28K
Gross Profit542.02K4.34K-4.82K-22.24K-40.28K
Operating Expenses8.52M4.02M2.21M2.60M3.05M
Selling, General & Admin6.79M2.73M880.77K994.34K1.20M
Research & Development1.72M1.29M1.33M1.61M1.85M
Other Operating Expenses-27.80K-1.87M724.93K-4.28MN/A
Operating Income-7.97M-4.01M-2.21M-2.60M-3.09M
Other Expenses / Income57.21K-4.14M-4.12M-4.66M-212.06K
Before Tax Income-7.92M-8.15M-6.32M-7.27M-3.30M
Income Tax Expenses20.99K2.46K1.95K2.75K3.20K
Net Income-7.94M-8.15M-6.33M-7.27M-3.31M
Interest Expenses37.12K2.53M1.00M382.17K214.83K
Basic Shares Outstanding8.75M4.50M7.38M7.38M7.38M
Diluted Shares Outstanding8.75M4.50M7.38M7.38M7.38M
EBITDA-7.72M-5.82M-1.48M-6.86M-3.05M
EBITDA Margin-304.98%-121,196.96%0.00%0.00%0.00%
EBIT-7.88M-5.62M-5.32M-6.88M-3.09M
EBIT Margin-311.11%-116,989.67%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙